NCT03932695

Investigation of Milk Peptides on Postprandial Blood Glucose Profile

Investigation of Milk Peptides on Postprandial Blood Glucose Profile: Randomized, Double-blind, Placebo-controlled, Cross-over Study With Different Dosages Followed by an Open-label Single Arm Phase to Estimate Long Term Effects

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: Ingredia S.A. · Industry
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Accepted

Summary

Aim of the study is to investigate the effect of two different dosages of milk peptides on postprandial blood glucose profile in prediabetic subjects compared to placebo. This will be investigated in a cross-over double blind randomized placebo controlled study design. Additionally, long term effects on glucose status, insulin sensitivity and postprandial blood glucose profile will be investigated in a follow up 6-week open label phase with the low dose only.

Conditions

• Postprandial Hyperglycemia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Low dose milk peptide	what is the effect of milk peptides 1400mg on postprandial glycemia after a meal rich in carbohydrates (75g)
DIETARY_SUPPLEMENT	High Dose milk peptide	what is the effect of milk peptides 2800mg on postprandial glycemia after a meal rich in carbohydrates (75g)
DIETARY_SUPPLEMENT	Placebo	what is the effect of placebo on postprandial glycemia after a meal rich in carbohydrates (75g)

Timeline

• Start date: 2018-09-26
• Primary completion: 2019-02-20
• Completion: 2019-04-30
• First posted: 2019-05-01
• Last updated: 2019-05-14

Locations

1 site across 1 country: Germany